Blackstone’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
Blackstone's SMMT Position: Q2 2026 in Review
Blackstone opened a new position in Summit Therapeutics (SMMT) in Q2 2026: 11,754 shares worth $171K. The stake represents ﹤0.01% of the portfolio and ranks #513 among its holdings.
243 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.
- Blackstone held 11,754 shares of Summit Therapeutics worth $171K as of Q2 2026.
- Summit Therapeutics was a new Blackstone position in Q2 2026.
- Summit Therapeutics made up ﹤0.01% of Blackstone's portfolio in Q2 2026, its #513 holding.
- 243 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.